Association Between Cytokines and Severity of Respiratory Syncytial Virus (RSV)-Induced Illness in the Elderly
NCT ID: NCT00609635
Last Updated: 2009-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2007-11-30
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Cytokines are chemicals that are naturally made by your body. Cytokine levels are increased in some people when they have common colds or wheezing caused by respiratory syncytial virus (RSV). The purpose of this study is to study the genes that may control cytokine levels during infection with RSV in the elderly population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years
NCT00405509
Effects of SinuSonic on Psychological and Physical Well-Being
NCT06268730
Effects of Allergic Rhinitis on the Nasal/Sinus Microbiome
NCT01461200
The Sinonasal Microbiome
NCT06822725
Immunologic Aspects of the Pathogenesis of Chronic Sinusitis in Children
NCT00004638
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis (based upon ICD-9-CM codes) for pneumonia, upper respiratory illness, bronchitis, COPD, asthma, viral illness, or congestive heart failure (CHF)
* Willing to sign informed consent.
Exclusion Criteria
* Subjects less that 65 years of age
* Subjects not diagnosed with a respiratory illness
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Academy of Allergy, Asthma, and Immunology
OTHER
West Penn Allegheny Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Allegheny General Hosptial Dept. of Allergy, Asthma, & Immunology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ritu Pabby, MD
Role: PRINCIPAL_INVESTIGATOR
West Penn Allegheny Health System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Adult RSV RC# 4212
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.